The production of IL-1 receptor antagonist in IFN-β-stimulated human monocytes depends on the activation of phosphatidylinositol 3-kinase but not of STAT1

Journal of Immunology

Volumn 174, Issue 5, 2005, Pages 2974-2980

  Molnarfi, Nicolas ^a   Hyka Nouspikel, Nevila ^a   Gruaz, Lyssia ^a   Bayer, Jean Michel ^a   Burger, Danielle ^a,b  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b University Hospital   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BETA INTERFERON; CYCLOHEXIMIDE; DACTINOMYCIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SERINE; SMALL INTERFERING RNA; STAT PROTEIN; STAT1 PROTEIN;

ARTICLE; CYTOKINE PRODUCTION; ENZYME ACTIVATION; GENE DISRUPTION; GENE INDUCTION; GENE KNOCKDOWN; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 14044273004     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.5.2974     Document Type: Article

References (53)

1. Burger, D., and J. M. Dayer. 2000. IL-1Ra. In Cytokine Reference. J. J. Oppenheim and M. Feldmann, eds. Academic Press, London, pp. 319-336.
2. Jenkins, J. K., and W. P. Arend. 1993. Interleukin 1 receptor antagonist production in human monocytes is induced by IL-1α, IL-3, IL-4 and GM-CSF. Cytokine 5:407.
3. Gabay, C., M. Dreyer, N. Pellegrinelli, R. Chicheportiche, and C. A. Meier. 2001. Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J. Clin. Endocrinol. Metab. 86:783.
4. Jungo, F., J. M. Dayer, C. Modoux, N. Hyka, and D. Burger. 2001. IFN-β inhibits the ability of T lymphocytes to induce TNF-α and IL-1β production in monocytes upon direct cell-cell contact. Cytokine 14:272.
5. Sciacca, F. L., N. Canal, and L. M. E. Grimaldi. 2000. Induction of IL-1 receptor antagonist by interferon β: implication for the treatment of multiple sclerosis. J. Neurovir. 6:S33.
6. Vannier, E., L. C. Miller, and C. A. Dinarello. 1992. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 89:4076.
7. Burger, D., and J. M. Dayer. 2002. The role of human T lymphocyte-monocyte contact in inflammation and tissue destruction. Arthritis Res. 4 (Suppl 3):S169.
8. Burger, D., and J. M. Dayer. 2002. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-α production in contact-mediated activation of monocytes by T lymphocytes. Ann. NY Acad Sci. 966:464.
9. Lucas, K., and R. Hohlfeld. 1995. Differential aspects of cytokines in the immunopathology of multiple sclerosis. Neurology 45:54.
10. Dayer, J. M., and W, P. Arend. 1997. Cytokines and growth factors. In Textbook of Rheumatology. W. N. Kelley, E. D. Harris, Jr., S. Ruddy, and C. S. Sledge, eds. W.B. Saunders, Philadelphia, pp. 267-286.
11. Yong, V. W., S. Chabot, O. Stuve, and G. Williams. 1998. Interferon β in the treatment of multiple sclerosis: mechanisms of action. Neurology 51:682.
12. Tak, P. P., B. A. 't Hart, M. C. Kraan, M. Jonker, T. J. Smeets, and F. C. Breedveld. 1999. The effects of interferon β treatment on arthritis. Rheumatology 38:362.
13. Van Holten, J., C. Plater-Zyberk, and P. P. Tak. 2002. Interferon-β for treatment of rheumatoid arthritis? Arthritis Res. 4:346.
14. Van Holten, J., K. Reedquist, P. Sattonet-Roche, T. J. Smeets, C. Plater-Zyberk, M. J. Vervoordeldonk, and P. P. Tak. 2004. Treatment with recombinant interferon-β reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis. Arthritis Res. Ther. 6:R239.
15. Khademi, M., E. Wallstrom, M. Andersson, F. Piehl, R. Di Marco, and T. Olsson. 2000. Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon β-1a treatment of multiple sclerosis. J. Neuroimmunol. 103:202.
16. Rudick, R. A., R. M. Ransohorf, J. C. Lee, R. Peppler, M. Yu, P. M. Mathisen, and V. K. Tuohy. 1998. In vivo effects of interferon β-1a on immunosuppressive cytokines in multiple sclerosis. Neurology 50:1294.
17. Karp, C. L., A. H. Boxel-Dezaire, A. A. Byrnes, and L. Nagelkerken. 2001. Interferon-β in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10? Curr. Opin. Neurol. 14:361.
18. Coclet-Ninin, J., J. M. Dayer, and D. Burger. 1997. Interferon-β not only inhibits interleukin-1β and tumor necrosis factor-α but stimulates interleukin-1 receptor antagonist production in human peripheral blood mononuclear cells. Eur. Cytokine Network 8:345.
19. Molnarfi, N., L. Gruaz, J. M. Dayer, and D. Burger. 2004. Opposite effects of IFNβ on cytokine homeostasis in LPS- and T cell contact-activated human monocytes. J. Neuroimmunol. 146:76.
20. Taniguchi, T., and A. Takaoka. 2001. A weak signal for strong responses: interferon-α/β revisited. Nat. Rev. Mol. Cell Biol. 2:378.
21. Velichko, S., T. C. Wagner, J. Turkson, R. Jove, and E. Croze. 2002. STAT3 activation by type I interferons is dependent on specific tyrosines located in the cytoplasmic domain of interferon receptor chain 2c: activation of multiple STATS proceeds through the redundant usage of two tyrosine residues. J. Biol. Chem. 277:35635.
22. Schindler, C., and S. E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621.
23. Taniguchi, T., and A. Takaoka. 2002. The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14:111.
24. Ivashkiv, L. B., and X. Hu. 2004. Signaling by STATs. Arthritis Res. Ther. 6:159.
25. Pfeffer, L. M., J. E. Mullersman, S. R. Pfeffer, A. Murti, W. Shi, and C. H. Yang. 1997. STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IF-NAR1 chain of the type I interferon receptor. Science 276:1418.
26. Uddin, S., B. Majchrzak, P. C. Wang, S. Modi, M. K. Khan, E. N. Fish, and L. C. Platanias. 2000. Interferon-dependent activation of the serine kinase PI 3′-kinase requires engagement of the IRS pathway but not the Stat pathway. Biochem. Biophys. Res. Commun. 270:158.
27. Rani, M. R. S., D. W. Leaman, Y. Han, S. Leung, E. Croze, E. N. Fish, A. Wolfman, and R. M. Ransohoff. 1999. Catalytically active TYK2 is essential for interferon-β-mediated phosphorylation of STAT3 and interferon-α receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase. J. Biol. Chem. 274:32507.
28. David, M., E. Petricoin III, C. Benjamin, R. Pine, M. J. Weber, and A. C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon α- and interferon β-stimulated gene expression through STAT proteins. Science 269:1721.
29. Guthridge, C. J., D. Eidlen, W. P. Arend, A. Gutierrez-Hartmann, and M. F. Smith, Jr. 1997. Lipopolysaccharide and Raf-1 kinase regulate secretory interleukin-1 receptor antagonist gene expression by mutually antagonistic mechanisms. Mol. Cell. Biol. 17:1118.
30. Dreyer, M. G., C. E. Juge-Aubry, C. Gabay, U. Lang, F. Rohner-Jeanrenaud, J. M. Dayer, and C. A. Meier. 2003. Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor κB/PU.1 binding site. Biochem. J. 370:591.
31. Vey, E., J. M. Dayer, and D. Burger. 1997. Direct contact with stimulated T cells induces the expression of IL-1β and IL-1 receptor antagonist in human monocytes: involvement of serine/threonine phosphatases in differential regulation. Cytokine 9:480.
32. Ohmori, Y., M. F. Smith, Jr., and T. A. Hamilton. 1996. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J. Immunol. 157:2058.
33. Learn, C. A., M. S. Boger, L. Li, and C. E. McCall. 2001. The phosphatidylinositol 3-kinase pathway selectively controls sIL-1RA not interleukin-1β production in the septic leukocytes. J. Biol. Chem. 276:20234.
34. Hyka, N., J. M. Dayer, C. Modoux, T. Kohno, C. K. Edwards III, P. Roux-Lombard, and D. Burger. 2001. Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97:2381.
35. 2 integrin by antibodies or soluble CD23 induces IL-1β production on primary human monocytes through mitogen-activated protein kinase-dependent pathways. Blood 95:3868.
36. 2 integrins by antibodies or soluble CD23 induces macrophage inflammatory protein 1α (MIP-1α) and MIP-1β production in primary human monocytes through a pathway dependent on nuclear factor-κB. Blood 97:2932.
37. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
38. Aittomaki, S., M. Pesu, B. Groner, O. A. Janne, J. J. Palvimo, and O. Silvennoinen. 2000. Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fcγ receptor I in monocytes. J. Immunol. 164:5689.
39. Aittomaki, S., J. Yang, E. W. Scott, M. C. Simon, and O. Silvennoinen. 2004. Molecular basis of Stat1 and PU.1 cooperation in cytokine-induced Fcγ receptor I promoter activation. Int. Immunol. 16:265.
40. Collart, M. A., D. Belin, J. D. Vassalli, S. de Kossodo, and P. Vassalli. 1986. γ Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164:2113.
41. Fenton, M. I., B. D. Clark, K. L. Collins, A. C. Webb, A. Rich, and P. E. Auron. 1987. Transcriptional regulation of the human prointerleukin 1β gene. J. Immunol. 138:3972.
42. Zinck, R., M. A. Cahill, M. Kracht, C. Sachsenmaier, R. A. Hipskind, and A. Nordheim. 1995. Protein synthesis inhibitors reveal differential regulation of mitogen-activated protein kinase and stress-activated protein kinase pathways that converge on Elk-1. Mol. Cell. Biol. 15:4930.
43. Uddin, S., E. N. Fish, D. A. Sher, C. Oardziola, M. F. White, and L. C. Platanias. 1997. Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-α. J. Immunol. 158:2390.
44. Blaskovich, M. A., J. Sun, A. Cantor, J. Turkson, R. Jove, and S. M. Sebti. 2003. Discovery of JSI-124 (cucuibitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res. 63:1270.
45. Constantinescu, S. N., E. Croze, C. Wang, A. Murti, L. Basu, J. E. Mullersman, and L. M. Pfeffer. 1994. Role of interferon α/β receptor chain 1 in the structure and transmembrane signaling of the interferon α/β receptor complex. Proc. Natl. Acad. Sci. USA 91:9602.
46. Wen, Z., Z. Zhong, and J. E. Darnell, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241.
47. Decker, T., and P. Kovarik. 2000. Serine phosphorylation of STATs. Oncogene 19:2628.
48. Kim, M. O., Q. Si, J. N. Zhou, R. G. Pestell, C. F. Brosnan, J. Locker, and S. C. Lee. 2002. Interferon-β activates multiple signaling cascades in primary human microglia. J. Neurochem. 81:1361.
49. Navarro, A., B. Anand-Apte, Y. Tanabe, G. Feldman, and A. C. Lamer. 2003. A PI-3 kinase-dependent, Stat1-independent signaling pathway regulates interferon-stimulated monocyte adhesion. J. Leukocyte Biol. 73:540.
50. Rhee, S. H., B. W. Jones, V. Toshchakov, S. N. Vogel, and M. J. Fenton. 2003. Toll-like receptors 2 and 4 activate STAT1 serine phosphorylation by distinct mechanisms in macrophages. J. Biol. Chem. 278:22506.
51. Foey, A. D., M. Feldmann, and F. M. Brennan. 2001. CD40 ligation induces macrophage IL-10 and TNF-α production: differential use of the PI3K and p42/44 MAPK-pathways. Cytokine 16:131.
52. Foey, A. D., P. Green, B. Foxwell, M. Feldmann, and F. Brennan. 2002. Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritis. Arthritis Res. 4:64.
53. Wymann, M. P., K. Bjorklof, R. Calvez, P. Finan, M. Thomast, A. Trifilieff, M. Barbier, F. Altruda, E. Hirsch, and M. Laffargue. 2003. Phosphoinositide 3-kinase γ: a key modulator in inflammation and allergy. Biochem. Soc. Trans. 31:275.